Allogene Therapeutics To Review Interim Futility Analysis For Phase 2 Trial Of Large B-Cell Lymphoma Treatment On April 13

Allogene

Allogene

ALLO

0.00

Allogene Therapeutics To Review Interim Futility Analysis For Phase 2 Trial Of Large B-Cell Lymphoma Treatment On April 13